Table 2.
Study Author (year) |
Anticancer Drug | Embolizing | Duration Days |
Compound Kushen Injection Dosage |
Injection Method |
||
LP | Agents | Adjuvant Drug | |||||
Cao et al., 2009 | 5-Fu, DDP, MMC | Yes | GS particles | MMC | 56<D<224 | given 20ml per time, once daily over 14 days; began in the TACE operation day; | I.v.drip |
Chen et al., 2006 | 5-Fu, DDP, EPI, | Na | Na | Na | 63 | given 20ml per time, once daily over 21 days; begin in the TACE operation day; | I.v.drip |
Chen et al., 2007 | 5-Fu, MMC, EPI, | Yes | Na | Na | 84<D<126 | given 20ml per time, once daily over the whole duration; | I.v.drip |
Deng et al., 2009 | THP-ADM | Yes | Na | Na | 61 | given 20ml per time, once daily over 14 days; begin in the 2nd day after TACE operation; | I.v.c. infusion |
Guan et al., 2006 | (5-Fu, DDP, ADM) or (THP-ADM,5-Fu, CBP) | Na | Na | Na | 45<D<60 | given 20ml per time, once daily over the whole duration; | I.v.drip |
Huang et al., 2006 | 5-Fu, ADM, HCPT | Yes | Na | Na | 56<D<224 | given 15∼30ml per time, once daily over 10∼20 days; begin in the TACE operation day; | I.v.drip |
Wang et al., 2009 | 5-Fu, DDP, ADM | Yes | GS particles | Na | 140<D<168 | given 20ml per time, once daily over 10 days; begin in the TACE operation day; | I.v.drip |
Xu et al., 2010 | 5-Fu, DDP,CF | Yes | Na | THP-ADM or HCPT | 60<D<120 | given 20ml per time, once daily over 15 days; begin in the 3rd day before TACE operation; | I.v.drip |
Yang, 2006 | DDP, MMC, ADM | Yes | GS particles | Na | 40<D<240 | given 20ml per time, once daily over 20 days; began in the TACE operation day; | I.v.drip |
Yu et al., 2010 | 5-Fu, ADM, HCPT | Yes | GS particles | Na | 84 | given 20ml per time, once daily over 15 days; begin in the TACE operation day; | I.v.drip |
5-Fu=fluorouracil, DDP=cisplatin, ADM=Adriamycin, CF=Calcium Folinate, EPI=Epirubicin, MMC=Mitomycin, THP-ADM=pirarubicin hydrochloride, CBP=carboplatin, HCPT=Hydroxycamptothecin, LP=Lipiodol, GS=Gelatin sponge, Na=not described, D=days, I.v.drip=intravenous drip, I.v.c.infusion=intravenous continuous infusion.